Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
5
×
cancer
5
×
life sciences
national blog main
new york blog main
5
×
biotech
clinical trials
national top stories
new york top stories
startups
boston
drug discovery
fda
ipo
new york
san francisco blog main
san francisco top stories
accent therapeutics
adeno-associated virus
aducanumab
agios pharmaceuticals
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
cara therapeutics
chemotherapy
cisplatin
codiak biosciences
community oncology alliance
cutaneous t-cell lymphoma
cvs health
What
medicines
5
×
ipo
new
helped
pipeline
activity
adding
ago
aim
aiming
approvals
balance
based
begin
bio
biogen
biosciences
bio’s
boost
brings
bubbles
build
cancer
cells
change
clamped
class
clinical
codiak
community
company’s
course
covid
decibel
delays
developing
development
diagnostics
discover
docs
Language
unset
Current search:
medicines
×
cancer
×
" boston top stories "
×
" new york blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
